Close menu




July 31st, 2025 | 07:10 CEST

Following in the footsteps of PayPal and Co.? Deutz and Veganz dare to spark a revolution

  • Food
  • Vegan
  • ecommerce
  • Defense
Photo credits: pexels

PayPal's share price climbed from USD 30 to over USD 260 in just four years – but what fueled the hype between 2016 and 2021? PayPal was perceived as a driver of innovation. Even back then, the market praised its significant market position and potential opportunities, for example, in cryptocurrencies. Just a few days ago, PayPal finally rolled out crypto payments within its platform. However, the market had already anticipated this move years ago. This shows that companies that the market believes will continue to innovate often receive advance praise in the form of sharply rising share prices. In addition to PayPal, we present two other innovation drivers of today that could become the new darlings of the markets.

time to read: 4 minutes | Author: Nico Popp
ISIN: PAYPAL HDGS INC.DL-_0001 | US70450Y1038 , DEUTZ AG O.N. | DE0006305006 , VEGANZ GROUP AG | DE000A3E5ED2

Table of contents:


    PayPal: Between hype and depression despite innovation

    PayPal is considered the world's leading digital payment service provider and earns its money from transaction fees. Just this month, the Company introduced crypto payments. This new feature allows customers to use various cryptocurrencies, including Bitcoin, Ethereum, and over 100 others, directly at the checkout of millions of merchants worldwide. A key advantage for merchants is that PayPal automatically and instantly converts the selected cryptocurrency into fiat currency at the point of sale. This means that merchants receive payments in their local currency without being exposed to the volatility of the crypto market. This innovation is expected to significantly reduce fees for cross-border transactions compared to traditional international credit card processing – observers estimate savings of up to 90% in some cases. These potential savings make international payments easier and more attractive for businesses of all sizes and could significantly expand PayPal's global commerce presence. But how is the market reacting? It remains skeptical!

    Despite good second-quarter figures, including earnings per share of USD 1.40, which exceeded analysts' expectations, higher revenue figures and a more optimistic outlook for 2025, the stock reacted cautiously. It seems that PayPal investors now see the glass as half empty – just five years ago, it was the other way around. Slightly declining transaction figures could be interpreted as new user behavior in light of the opportunities offered by crypto payments, but the market sees this as a warning sign. This situation does not bode well for PayPal shares in the short term, but opportunities will arise in the long term. However, the market will have to rethink its position.

    Deutz: Defense saves the figures

    Engine specialist Deutz has also rethought its strategy and is now more involved in the military sector than before. In 2024, the Cologne-based industrial supplier acquired the Polish company BTH FAST, enabling it to supply engines for military vehicles. Although the figures for the first quarter of 2025 were mixed, Deutz reported a 30.3% increase in order intake and explicitly attributed this to its recent M&A strategy. Its involvement in the defense sector is therefore paying off. Deutz had already been involved in the areas of decentralized energy solutions and electric and hydrogen combustion engines. Analysts are mostly positive about Deutz shares in July 2025. Of the three analysts who have issued price targets in the last three months, all rate the stock as "Buy" or "Strong Buy." The average 12-month price target is EUR 10.60. This corresponds to an upside potential of 37.66% compared to the current level. However, after a 65% rise in six months, the cyclical stock could also consolidate.

    Will Veganz soon be making millions with Mililk?

    The Veganz share has already consolidated: from prices above EUR 90, the value plummeted to EUR 5. However, it has been on the rise again for several months now. The share price recovery could also be due to the innovations that the Company is pushing forward. The subsidiary Mililk FoodTech GmbH aims to revolutionize the market for plant-based milk alternatives. Specifically, it involves a specially developed 2D printing process for delivering oat milk and other products in sheets. The milk, which is highly concentrated in this form, can be re-liquefied without any loss of quality and in organic quality. Mililk's approach is specifically aimed at catering businesses such as coffee house chains and fast food restaurants. Thanks to Veganz's technology, the plant-based milk alternative prepared in this way has a long shelf life, is up to 85% lighter and therefore easier to store without refrigeration. This reduces costs for both storage and transport and significantly reduces packaging waste.**

    About two weeks ago, Veganz announced a capital increase of EUR 7.1 million to strengthen its equity base and drive forward the expansion of Mililk. What makes this special is that the Company, which has primarily been active in the DACH region to date, has already selected a production site in the US to launch Mililk there. The country, which is home to system catering and where every small town has several branches of the most important franchise chains, is predestined for this. Veganz aims to have the plant in the US up and running by 2026.

    Higher price targets are on the cards thanks to the sale of shares – is the stock due for a revaluation?

    In addition to the excitement surrounding Mililk, Veganz could also benefit from the planned sale of its subsidiary OrbiFarm GmbH, which is expected to fetch EUR 30 million plus profit sharing. The analysts at mwb research see a EUR 10.80 higher price target in this case – currently, the analysts have set a price target of EUR 21.50 for the Veganz share. If the sale of OrbiFarm goes ahead, an update is therefore to be expected – the new price potential could then exceed the EUR 30 mark and thus be around 50% above the current price. The changes in the investment portfolio and the expansion into the US with an innovative product could be a game-changer for Veganz. The examples of PayPal and Deutz show that the capital market rewards innovation and consistent business development. Veganz shares are still far from overvalued. On the contrary, the current valuation does not yet seem to fairly reflect Veganz's substance and potential.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Fabian Lorenz on September 19th, 2025 | 07:00 CEST

    Buy Nordex shares? RENK is betting on vehicle manufacturing! Is Graphano Energy too cheap?

    • Mining
    • graphite
    • Defense
    • Automotive
    • renewableenergies

    No battery works without graphite. At the same time, the raw material is scarce and geopolitically sensitive. This benefits Graphano Energy. Is the stock undervalued? The Company is facing important months ahead. RENK shares are not cheap. But the supercycle in the defense industry is expected to generate strong profits over the coming decade. To handle the anticipated flood of orders, RENK is relying on production standards from the automotive industry. And what about Nordex? Investors are concerned about political headwinds. But analysts are offering reassurance and recommend buying the stock.

    Read

    Commented by André Will-Laudien on September 18th, 2025 | 07:20 CEST

    Margins war and soaring commodity prices! Caution advised on BYD, Mercedes, RENK, and European Lithium

    • Mining
    • Lithium
    • Batteries
    • Commodities
    • Electromobility
    • Defense

    So far, September has turned out to be a month of bliss. It appears that the stock market already underwent its full correction back in April. Investors are still buying high-tech and AI stocks, seemingly unconcerned by valuations of historic proportions. In the wake of this super bull market, automakers BYD and Mercedes have recently suffered significant price corrections. At the same time, the wave of euphoria surrounding defense stock RENK now appears somewhat exaggerated. The rally around critical metals has also driven European Lithium and its US subsidiary Critical Metals significantly higher. With commodity prices recently exploding, however, the rally here is likely only just beginning. We take a closer look at the numbers.

    Read

    Commented by Fabian Lorenz on September 18th, 2025 | 07:10 CEST

    MAJOR DEVELOPMENTS for megatrend stocks: Rheinmetall, BioNTech, First Hydrogen

    • Hydrogen
    • cleantech
    • Biotechnology
    • Defense

    Rheinmetall is going full throttle: on land, at sea, in the air, and even in space. Its latest bombshell is the announced takeover of Lürssen's naval division. Will this provide the tailwind the stock needs to break through the EUR 2,000 mark on a sustained basis? Analysts view the transaction positively, though some cautionary voices remain. Meanwhile, a major development in Canada is boosting sentiment around First Hydrogen. North Americans aim to be at the forefront of the small modular reactors (SMRs) movement. The potential is enormous. BioNTech also holds significant promise in the fight against cancer. However, challenges have emerged - ironically in the world's largest pharma market. The US government plans to cut or even stop funding for new mRNA vaccine development. BioNTech shares reacted accordingly and may break through their sideways trend downwards.

    Read